Brain+ A/S (CPH:BRAINP)

Market Cap	11.75M
Revenue (ttm)	7.86M
Net Income (ttm)	-12.05M
Shares Out	652.72M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,279,660
Average Volume	3,712,086
Open	0.0190
Previous Close	0.0176
Day's Range	0.0180 - 0.0190
52-Week Range	0.0119 - 0.2000
Beta	-0.65
RSI	37.43
Earnings Date	Apr 29, 2025

About Brain+

Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia. It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a dementia population at limited costs; CST/ computerized cogn...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 12
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: BRAINP

Financial Performance

In 2024, Brain+'s revenue was 7.86 million, an increase of 28.08% compared to the previous year's 6.14 million. Losses were -12.05 million, -37.02% less than in 2023.